Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Encompass Health Affirms FY2025 Adj EPS Guidance of $5.12-$5.34 vs $5.28 Est; Affirms FY2025 Sales Guidance of $5.880B-$5.980B vs $5.935B Est

Author: Benzinga Newsdesk | September 12, 2025 07:07am
Encompass Health (NYSE:EHC) affirms FY2025 Adj EPS guidance from $5.12-$5.34 to $5.12-$5.34 vs $5.28 analyst estimate. Affirms FY2025 sales outlook from $5.880 billion-$5.980 billion to $5.880 billion-$5.980 billion vs $5.935 billion estimate.

Posted In: EHC


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist